Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF ‐/ MEK ‐inhibitor treatment—A case report and review of the literature
Genes, Chromosomes and Cancer · 2024
DOI: 10.1002/gcc.23222 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, Chromosomes and Cancer, 2024. Verfasst von Lennart von Fritsch und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University Hospital of Schleswig-Holstein, Campus Luebeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Carcinoma, Acinar Cell, Pancreatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Pancreatic acinar cell carcinomas are rare malignant neoplasms. High‐quality evidence about the best treatment strategy is lacking. We present the case of a 52‐year‐old male with a BRAF V600E ‐mutated PACC who experienced a complete remission after chemotherapy with BRAF‐/MEK‐inhibitors. Case The patient presented with upper abdomen pain, night sweat, and weight loss. CT scan showed a pancreatic tumor extending from the pancreas head to body. Histological workup identified an acinar cell carcinoma. As the tumor was inoperable, chemotherapy with FOFIRNIOX was initiated and initially showed a slight regression of disease. The regimen had to be discontinued due to severe side effects. Molecular analysis identified a BRAF V600E mutation, so the patient was started on BRAF‐ and MEK‐inhibitors (dabrafenib/trametinib). After 16 months, CT scans showed a near complete remission with a markedly improved overall health.
Discussion
Studies suggest that up to one‐fourth of PACCs carry a BRAF mutation and might therefore be susceptible to a BRAF‐/MEK‐inhibitor therapy. This offers a new therapeutic pathway to treat this rare but malignant neoplasm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University Hospital of Schleswig-Holstein, Campus Luebeck, Lübeck, Germany.
- Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Lübeck, Germany.
- Luebecker Onkologische Schwerpunktpraxis, Lübeck, Germany.
- Institute of Pathology, University Hospital Schleswig-Holstein, Campus Luebeck, Lübeck, Germany.
ORCID-Profile: Lennart von Fritsch, Nikolas von Bubnoff
Zitieren
APA
von Fritsch, L., von Bubnoff, N., Weber, K., Kirfel, J., Schreiber, C., Keck, T., & Wellner, U. (2024). Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF ‐/ MEK ‐inhibitor treatment—A case report and review of the literature. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23222
Vancouver
von Fritsch L, von Bubnoff N, Weber K, Kirfel J, Schreiber C, Keck T, et al. Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF ‐/ MEK ‐inhibitor treatment—A case report and review of the literature. Genes, Chromosomes and Cancer. 2024. doi:10.1002/gcc.23222
BibTeX
@article{vonFritsch2024,
author = {von Fritsch, Lennart and von Bubnoff, Nikolas and Weber, Klaus and Kirfel, Jutta and Schreiber, Cleopatra and Keck, Tobias and Wellner, Ulrich},
title = {Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF ‐/ MEK ‐inhibitor treatment—A case report and review of the literature},
journal = {Genes, Chromosomes and Cancer},
year = {2024},
doi = {10.1002/gcc.23222}
}
EUVIMED